Reduction in CNS scar formation without concomitant increase in axon regeneration following treatment of adult rat brain with a combination of antibodies to TGFβ1 and β2

European Journal of Neuroscience

Volumn 14, Issue 10, 2001, Pages 1667-1677

  Moon, L D F ^a,b   Fawcett, J W ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b UNIVERSITY OF MIAMI   (United States)

Author keywords

Central nervous system; Glia; Regeneration; Scar; Transforming growth factor

Indexed keywords

GLIAL FIBRILLARY ACIDIC PROTEIN; ISOPROTEIN; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA2;

ANESTHESIA; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY LABELING; ARTICLE; ASTROCYTE; BRAIN INJURY; CANNULA; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; DRUG EFFECT; ENCEPHALITIS; GLIOSIS; IMMUNOCOMPETENT CELL; IMPLANTATION; MACROPHAGE; MICROGLIA; NERVE FIBER GROWTH; NERVE FIBER REGENERATION; NERVE FIBER TRANSECTION; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; PRIORITY JOURNAL; RAT; SCAR FORMATION;

ANIMALS; ANTIGENS; ASTROCYTES; AXONS; BRAIN INJURIES; CICATRIX; GLIAL FIBRILLARY ACIDIC PROTEIN; GLIOSIS; IMMUNOHISTOCHEMISTRY; MACROPHAGE-1 ANTIGEN; MACROPHAGES; MICROGLIA; NEOSTRIATUM; NERVE REGENERATION; OLIGODENDROGLIA; PROTEOGLYCANS; RATS; RATS, SPRAGUE-DAWLEY; STEM CELLS; SUBSTANTIA NIGRA; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA2;

EID: 0035784404     PISSN: 0953816X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.0953-816X.2001.01795.x     Document Type: Article

References (27)

1. Asher, R.A., Morgenstern, D.A., Adcock, K.A., Rogers, J.H. & Fawcett, J.W. (1999) Versican is up-regulated in CNS injury and is a product of O-2A lineage cells. Soc. Neurosci. Abstr., 25, 750.
2. Asher, R.A., Morgenstern, D.A., Fidler, P.S., Adcock, K.A., Oohira, A., Braistead, J.E., Levine, J.M., Margolis, R.K., Rogers, J.H. & Fawcett, J.W. (2000) Neurocan is upregulated in injured brain and in cytokine-treated astrocytes. J. Neurosci., 20, 2427-2438.
3. Avnur, Z. & Geiger, G. (1984) Immunocytochemical localization of native chondroitin-sulfate in tissues and cultured cells using a specific monoclonal antibody. Cell, 38, 811-822.
4. Baghdassarian-Chalaye, D., Tour-Delbauffe, D., Gavaret, J.M. & Pierre, M. (1993) Effects of transforming growth factor b1 on the extracellular matrix and cytoskeleton of cultured astrocytes. Glia, 7, 193-202.
5. Brecknell, J.E., Dunnett, S.B. & Fawcett, J.W. (1995) A quantitative study of cell death in the substantia nigra following a mechanical lesion of the medial forebrain bundle. Neuroscience, 64, 219-227.
6. Brecknell, J.E. & Fawcett, J.W. (1996) Axonal regeneration. Biol. Rev., 71, 227-255.
7. Flanders, K., Ludecke, G., Renzing, J., Hamm, C., Cissel, D. & Unsicker, K. (1993) Effects of TGFbs and bFGF on astroglial cell growth and gene expression in vitro. Mol. Cell. Neurosci., 4, 406-417.
8. Fok-Seang, J., DiProspero, N.A., Meiners, S., Muir, E. & Fawcett, J.W. (1998) Cytokine-induced changes in the ability of astrocytes to support migration of oligodendrocyte precursors and axon growth. Eur. J. Neurosci., 10, 2400-2415.
9. Krieglstein, K., Rufer, M., Suter-Crazzolara, C. & Unsicker, K. (1995) Neural functions of the transforming growth factors beta. Int. J. Dev. Neurosci., 13, 301-315.
10. Lips, K., Stichel, C.C. & Müller, H.W. (1995) Restricted appearance of tenascin and chondroitin sulphate proteoglycans after transection and sprouting of adult rat postcommissural fornix. J. Neurocytol., 24, 449-464.
11. Logan, A., Baird, A. & Berry, M. (1999a) Decorin attenuates gliotic scar formation in the rat cerebral hemispheres. Exp. Neurol., 159, 504-510.
12. Logan, A. & Berry, M. (1993) Transforming growth factor beta 1 and basic fibroblast growth factor in the injured CNS. Trends Pharmacol. Sci., 14, 397-343.
13. Logan, A., Frautschy, S.A., Gonzalez, A.M., Sporn, M.B. & Baird, A. (1994) Effects of transforming growth factor beta 1 on scar production in the injured central nervous system. Eur. J. Neurosci., 6, 355-363.
14. Logan, A., Green, J., Hunter, A., Jackson, R. & Berry, M. (1999b) Inhibition of glial scarring in the injured rat brain by a recombinant human monoclonal antibody to transforming growth factor beta 2. Eur. J. Neurosci., 11, 2367-2374.
15. McCartney-Francis, N.L. & Wahl, S.M. (1994) Transforming growth factor beta: A matter of life and death. J. Leukocyte Biol., 55, 401-409.
16. Moon, L.D.F., Asher, R.A., Rhodes, K.E. & Fawcett, J.W. (2001) Regeneration of CNS axons back to their target following treatment of adult rat brain with chondroitinase ABC. Nature Neurosci., 4, 465-466.
17. Moon, L.D.F., Brecknell, J.E., Franklin, R.J., Dunnett, S.B. & Fawcett, J.W. (2000) Robust regeneration of CNS axons through a track depleted of CNS glia. Exp. Neurol., 161, 49-66.
18. Nath, R.K., Kwon, B., Mackinnon, S.E., Jensen, J.N., Reznik, S. & Boutros, S. (1998) Antibody to transforming growth factor beta reduces collagen production in injured peripheral nerve. Plastic Reconstructive Surg., 102, 1100-1108.
19. Nishiyama, A., Chang, A. & Trapp, B. (1999) NG2+ glial cells: A novel glial cell population in the adult brain. J. Neuropath. Exp. Neurol., 58, 1113-1124.
20. Paxinos, G. & Watson, C. (1986) The Rat Brain in Stereotaxic Coordinates. Academic Press, Sydney.
21. Raivich, G., Bohatschek, M., Kloss, C.U.A., Werner, A., Jones, L.J. & Kreutzberg, G.W. (1999) Neuroglial activation repertoire in the injured brain: Graded response, molecular mechanisms and cues to physiological function. Brain Res. Rev., 30, 77-105.
22. Schnadelbach, O., Mandl, C. & Faissner, A. (1998) Expression of DSD-1 PG in primary neural and glial-derived cultures, upregulation by TGF-beta and implications for cell-substrate interactions of the glial cell line oli-neu. Glia, 23, 99-119.
23. Sinclair, S.R., Svendsen, C.N., Torres, E.M., Martin, D., Fawcett, J.W. & Dunnett, S.B. (1996) GDNF enhances dopaminergic cell survival and fiber outgrowth in embryonic nigral grafts. Neuroreport, 7, 2547-2552.
24. Smith, G.M. & Hale, J.H. (1997) Macrophage/microglia regulation of astrocyte tenascin: Synergistic action of transforming growth factor beta and basic fibroblast growth factor. J. Neurosci., 17, 9624-9633.
25. Sorrell, J.M., Carrino, D.A. & Caplan, A.I. (1993) Structural domains in chondroitin sulfate identified by anti-chondroitin sulfate monoclonal antibodies. Immunosequencing of chondroitin sulfates. Matrix, 13, 351-361.
26. Varga, J., Rosenbloom, J. & Jiminez, S.A. (1987) Transforming growth factor beta causes a persistent increase in steady-state amounts for type I and type II collagen and fibronectin mRNAs in normal dermal human fibroblasts. J. Biochem., 297, 597-604.
27. Wilby, M.W., Sinclair, S.R., Muir, E.M., Zeitlow, R., Adcock, K.A., Horellou, P., Rogers, J.H., Dunnett, S.B. & Fawcett, J.W. (1999) A glial cell line-derived neurotrophic factor-secreting clone of the schwann cell line SCTM41 enhances survival and fiber outgrowth from embryonic nigral neurons grafted to the striatum and to the lesioned substantia nigra. J. Neurosci. 19, 2301-2312.